Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 2,061 - 2,080 results of 21,342 for search '(( significant decrease decrease ) OR ( significance ((a decrease) OR (mean decrease)) ))', query time: 0.47s Refine Results
  1. 2061
    Complete results of regression analyses of the candidate gene approach.

    Complete results of regression analyses of the candidate gene approach. by Dai Nogimura (21445649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2062
    eQTL analysis for proxy SNPs of <i>PRMT6</i>-<i>NTNG1</i> rs12028323.

    eQTL analysis for proxy SNPs of <i>PRMT6</i>-<i>NTNG1</i> rs12028323. by Dai Nogimura (21445649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2063
    Inhibition of PGAM5 and apoptosis prevented <i>T. spiralis</i> larval invasion of Caco-2 monolayer.

    Inhibition of PGAM5 and apoptosis prevented <i>T. spiralis</i> larval invasion of Caco-2 monolayer. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2064
    rTsSPc induced Caco-2 cell apoptosis.

    rTsSPc induced Caco-2 cell apoptosis. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2065
    Apoptosis inhibitor abolished and restored rTsSPc-disrupted Caco-2 monolayer barrier integrity.

    Apoptosis inhibitor abolished and restored rTsSPc-disrupted Caco-2 monolayer barrier integrity. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2066
    PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity.

    PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2067
    (A and B) ChIP-qPCR analysis of HSF2 binding to the indicated KSHV genomic regions expressed as % of input in KSHV infected latent (A) and lytic (B) cells.

    (A and B) ChIP-qPCR analysis of HSF2 binding to the indicated KSHV genomic regions expressed as % of input in KSHV infected latent (A) and lytic (B) cells. by Lorenza Cutrone (21144285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2068
    Inhibition of PGAM5 and apoptosis alleviated the rTsSPc-damaged Caco-2 monolayer barrier integrity.

    Inhibition of PGAM5 and apoptosis alleviated the rTsSPc-damaged Caco-2 monolayer barrier integrity. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2069
    rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells.

    rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells. by Qi Qi Lu (17721401)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2070
    Funnel plots of studies included in the meta-analysis assessing

    Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2071
    Overall analysis of randomized controlled trials.

    Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2072
    Newcastle-Ottawa scale.

    Newcastle-Ottawa scale. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2073
    Meta-analysis showing the overall effect of different statin types versus placebo for

    Meta-analysis showing the overall effect of different statin types versus placebo for by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2074
    Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for

    Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2075
    Reason for exclusion of all 6514 screened articles.

    Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2076
    Methodological items for non-randomized studies (MINORS).

    Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2077
    Jadad Score of randomized controlled trials.

    Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2078
    Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.

    Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2079
    Analysis of randomized controlled trials stratified based on treatment duration.

    Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2080
    PRISMA flow diagram of the systematic literature search process.

    PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: